Research analysts at Cantor Fitzgerald issued their FY2024 EPS estimates for shares of GH Research in a report released on ...
Cantor Fitzgerald assumed coverage on shares of GH Research (NASDAQ:GHRS – Free Report) in a research report sent to investors on Thursday morning, Marketbeat Ratings reports. The firm issued an ...
5d
Fintel on MSNCantor Fitzgerald Initiates Coverage of GH Research (GHRS) with Overweight RecommendationFintel reports that on February 13, 2025, Cantor Fitzgerald initiated coverage of GH Research (NasdaqGM:GHRS) with a ...
GH Research PLC (NASDAQ:GHRS) has received an Overweight rating from Cantor Fitzgerald, with a price target set at $14.00. The new coverage is based on the potential of GHRS's GH001, an inhaled ...
Cantor Fitzgerald initiated coverage of GH Research (GHRS) with an Overweight rating and $14 price target Maximize Your Portfolio with Data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results